Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sangamo Therapeutics (SGMO)

Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 86,787
  • Shares Outstanding, K 178,906
  • Annual Sales, $ 176,230 K
  • Annual Income, $ -257,830 K
  • 60-Month Beta 1.39
  • Price/Sales 0.52
  • Price/Cash Flow 14.72
  • Price/Book 1.16
Trade SGMO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.93
  • Most Recent Earnings $-0.34 on 03/13/24
  • Latest Earnings Date 05/13/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 243.84% ( +95.98%)
  • Historical Volatility 131.81%
  • IV Percentile 74%
  • IV Rank 22.94%
  • IV High 1,058.08% on 11/14/23
  • IV Low 1.50% on 08/15/23
  • Put/Call Vol Ratio 0.11
  • Today's Volume 10
  • Volume Avg (30-Day) 332
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 17,291
  • Open Int (30-Day) 15,770

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.22
  • Number of Estimates 5
  • High Estimate -0.10
  • Low Estimate -0.27
  • Prior Year 0.12
  • Growth Rate Est. (year over year) -283.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4702 +9.68%
on 04/19/24
0.9782 -47.28%
on 03/21/24
-0.2543 (-33.03%)
since 03/19/24
3-Month
0.4110 +25.47%
on 01/26/24
1.4800 -65.16%
on 02/16/24
+0.0836 (+19.35%)
since 01/19/24
52-Week
0.2911 +77.16%
on 11/13/23
1.7800 -71.03%
on 04/27/23
-1.1193 (-68.46%)
since 04/19/23

Most Recent Stories

More News
Sangamo: Q4 Earnings Snapshot

Sangamo: Q4 Earnings Snapshot

SGMO : 0.5136 (+5.88%)
Sangamo: Q3 Earnings Snapshot

Sangamo: Q3 Earnings Snapshot

SGMO : 0.5136 (+5.88%)
Sangamo: Q2 Earnings Snapshot

Sangamo: Q2 Earnings Snapshot

SGMO : 0.5136 (+5.88%)
Sangamo Therapeutics to Present Pre-clinical Data From Its Genomic Engineering Platform at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted 14 Sangamo abstracts for presentation at the...

SGMO : 0.5136 (+5.88%)
Sangamo Therapeutics Announces Strategic Update and Reports Preliminary First Quarter 2023 Financial Results

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced recent business highlights, including a strategic pipeline prioritization and restructuring, and reported certain...

SGMO : 0.5136 (+5.88%)
Strength Seen in Pharming Group N.V. Sponsored ADR (PHAR): Can Its 5.2% Jump Turn into More Strength?

Pharming Group N.V. Sponsored ADR (PHAR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there...

PHAR : 9.35 (+0.21%)
SGMO : 0.5136 (+5.88%)
Sangamo Therapeutics Announces First Quarter 2023 Conference Call and Webcast

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company is scheduled to release its first quarter 2023 financial results after the market closes on Wednesday,...

SGMO : 0.5136 (+5.88%)
Sangamo (SGMO) Loses -37.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Sangamo (SGMO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in...

SGMO : 0.5136 (+5.88%)
Sangamo (SGMO) Loses -24.09% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Sangamo (SGMO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings...

SGMO : 0.5136 (+5.88%)
Sangamo Therapeutics (SGMO) Reports Q4 Loss, Tops Revenue Estimates

Sangamo (SGMO) delivered earnings and revenue surprises of 11.11% and 0.83%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SGMO : 0.5136 (+5.88%)
XENE : 40.08 (-0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 0.5652
2nd Resistance Point 0.5476
1st Resistance Point 0.5163
Last Price 0.5136
1st Support Level 0.4674
2nd Support Level 0.4498
3rd Support Level 0.4185

See More

52-Week High 1.7800
Fibonacci 61.8% 1.2112
Fibonacci 50% 1.0355
Fibonacci 38.2% 0.8599
Last Price 0.5136
52-Week Low 0.2911

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar